Response Prediction for Anti-angiogenic Treatment in Recurrent Glioblastoma

Clinical trial NCT04143425 · COMPLETED

Trial details

NCT number: NCT04143425
Sponsor: Ho Sung Kim
Status: COMPLETED
Study type: OBSERVATIONAL

Adult Glioblastoma Magnetic Resonance Imaging Bevacizimab

Start date: 2020-02-06
Primary completion: 2021-08-31
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.